EUVIMEDEUVIMED entdecken
Crossref

Growth failure in aggrecan deficiency is due to decreased extracellular matrix and impaired growth plate chondrocyte hypertrophy

Ameya Bendre, Lars Ottosson, Marta Baroncelli, Zelong Dou, Ola Nilsson

Bone · 2025-11 · 200 · 117594

DOI: 10.1016/j.bone.2025.117594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2025-11. Verfasst von Ameya Bendre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet, Stockholm,…. Hauptthemen laut MEDLINE: Aggrecans, Chondrocytes, Extracellular Matrix, Growth Plate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Wera Ekstrom Foundation Fund for Pediatric Research, IngaBritt and Arne Lundberg Foundation, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous loss-of-function mutations in the aggrecan (ACAN) gene cause autosomal dominant short stature often associated with advanced bone age, early-onset osteoarthritis and intervertebral disc disease (SSOAOD). These mutations are relatively common in patients with idiopathic short stature. However, the pathogenic mechanism of growth failure in this condition is not fully understood. Here, we studied the heterozygous cartilage matrix deficiency mouse (Acan+/-), which harbors a 7 bp microdeletion in aggrecan and develops postnatal growth cessation despite being born of normal size. Using detailed histomorphometric analysis, we found that the growth failure was primarily due to decreased extracellular matrix and impaired chondrocyte hypertrophy, whereas proliferation was largely unaffected. Furthermore, single-cell transcriptomic profiling revealed decreased total Acan mRNA expression in the Acan+/- chondrocytes. Notably, Akt signalling, which is important for hypertrophic differentiation was suppressed in Acan+/- pre-hypertrophic and hypertrophic chondrocytes. The decreased Akt signalling was associated with increased expression of calcium-calmodulin dependent protein kinase 1D (Camk1D), which negatively regulates Akt signalling, thereby providing a potential mechanism for the impaired hypertrophic differentiation. These findings reveal key cellular and molecular causes of growth failure in aggrecan deficiency and suggest that boosting proteoglycan expression and Akt signalling may help restore growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AggrecansChondrocytesExtracellular MatrixGrowth PlateAnimalsHypertrophyMiceProto-Oncogene Proteins c-aktSignal TransductionCell ProliferationCell Differentiation

Stichwörter der Autor:innen

Aggrecan mutationsChondrocyte hypertrophyExtracellular matrixGrowth failureShort stature

Substanzen

AggrecansProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology and Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Division of Pediatric Endocrinology and Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Pediatric Endocrinology, Astrid Lindgren Childr…

Förderung

  • Wera Ekstrom Foundation Fund for Pediatric Research
  • IngaBritt and Arne Lundberg Foundation
  • Karolinska Institutet
  • Novo Nordisk Foundation
  • Foundation Masonic Home for Children in Stockholm
  • Vetenskapsrådet
  • Edith and Erik Fernströms Foundation for Medical Research
  • Promobilia foundation

Zitieren

APA

Bendre, A., Ottosson, L., Baroncelli, M., Dou, Z., & Nilsson, O. (2025). Growth failure in aggrecan deficiency is due to decreased extracellular matrix and impaired growth plate chondrocyte hypertrophy. Bone, 200, 117594. https://doi.org/10.1016/j.bone.2025.117594

Vancouver

Bendre A, Ottosson L, Baroncelli M, Dou Z, Nilsson O. Growth failure in aggrecan deficiency is due to decreased extracellular matrix and impaired growth plate chondrocyte hypertrophy. Bone. 2025;200:117594. doi:10.1016/j.bone.2025.117594

BibTeX
@article{Bendre2025,
  author = {Bendre, Ameya and Ottosson, Lars and Baroncelli, Marta and Dou, Zelong and Nilsson, Ola},
  title = {Growth failure in aggrecan deficiency is due to decreased extracellular matrix and impaired growth plate chondrocyte hypertrophy},
  journal = {Bone},
  year = {2025},
  volume = {200},
  pages = {117594},
  doi = {10.1016/j.bone.2025.117594}
}
Kostenlos starten →